Effects of cytokines and nitric oxide on myocardial E-C coupling

Basic Research in Cardiology

Volumn 93, Issue 1 SUPPL., 1998, Pages 86-94

  Haque, R ^a   Kan, H ^a   Finkel, M S ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Congestive heart failure; Cytokines; Myocardium; Nitric oxide

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYTOKINE; NITRIC OXIDE;

ARTICLE; CHRONOTROPISM; CONGESTIVE HEART FAILURE; DESENSITIZATION; EXCITATION CONTRACTION COUPLING; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; INFLAMMATION; INOTROPISM; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; HEART FAILURE, CONGESTIVE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; NITRIC OXIDE;

EID: 0031739921     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s003950050227     Document Type: Article

References (98)

1. Abbas AK, Lichtman AH, Pober JS (1991) Cellular and Molecular Immunology. Philadelphia: W. B. Saunders Company, pp 226-242
2. Abramson JJ (1987) Regulation of the sarcoplasmic reticulum calcium permeability by sulfhydryl oxidation and reduction. J Memb Sci 33: 241-248
3. Abramson JJ, Trimm JL, Weden L and Salama G (1983) Heavy metals induce rapid calcium release from sarcoplasmic reticulum vesicles isolated from skeletal muscle. Proc Natl Acad Sci USA 80: 1526-1530 (Pubitemid 13052443)
4. Baan CC, Van Emmerik NEM, Balk AHMM, Quint WGV, Mochtar B, Jutte NHPM, Niesters HGM, Weimar W (1994) Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin and Exp Immunol 97 (2): 293-298 (Pubitemid 24263073)
5. Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, Smith TW, Michel T (1994) Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. J Biol Chem 269: 27580-27588
6. Balligand JL, Ungureann D, Kelly RA, Kobzik L, Pimental D, Michael T, Smith TW (1993) Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follow exposure to activated macrophage-conditioned medium. J Clin Invest 91: 2314-2319 (Pubitemid 23141511)
7. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW and Michel T (1995) Nitric oxidedependent parasympathetic signaling is due to activation of constitutive endothelial (Type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270 (4): 14582-14586
8. Barry WH (1994) Mechanisms of Immunemediated myocyte injury. Circ 89: 2421-2432
9. Bers DM (1991) Excitation-Contraction Coupling and Cardiac Contractile Force. Norwell: Kluwer Academic Publishers, pp 119-145
10. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol (Heart Circ Physiol 32) 263: H1963- H1966 (Pubitemid 23030755)
11. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176-H182 (Pubitemid 23224707)
12. Braunwald E and Kloner RA (1982) The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 66: 1146-1149 (Pubitemid 13238825)
13. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351: 714-718 (Pubitemid 21896670)
14. Brown AM and Birnbaumer L (1988) Direct G protein gating of ion channels. Am J Physiol 254: H401-H410
15. Brown JH and Jones LG (1986) Phosphoinositide metabolism in the heart. In: Putney JW Jr. (ed) Phosphoinositides and Receptor Mechanisms. Alan R. Liss, pp 245-270
16. Charlat ML, O'Neill PG, Hartley CJ, et al. (1989) Prolonged abnormalities of left ventricular diastolic wall thinning in the "stunned" myocardium in conscious dogs: Time course and relation to systolic function. J Am Coll Cardiol 13: 185-194 (Pubitemid 19028697)
17. Cohn JN, Levine TB, Olivari MT, et al. (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Eng J Med 311: 819
18. Cristmas JW, Holden EP, Blackwell TS (1995) Strategies for blocking the systemic effects of cytokines in the sepsis syndrome. Crit Care Med 23: 955-963
19. Dilsizian V, Bonow RO (1993) Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation 87 (1): 1-20 (Pubitemid 23019329)
20. Dinerman JL, Lowenstein CJ, Snyder SH (1993) Molecular mechanisms of nitric oxide regulation: Potential relevance to cardiovascular disease. Circ Res 73 (No 2): 217-222 (Pubitemid 23212101)
21. Ellis SG, Henschke CI, Sandor T, et al. (1983) Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. J Am Coll Cardiol 1: 1047-1055 (Pubitemid 13107525)
22. Ellrodt AG, Riedinger MS, Kimchi A, Berman DS, Maddahi J, Swan HJC, Murata GH (1985) Left ventricular performance in septic shock: Reversible segmental and global abnormalities. Am Heart J 110: 402-409 (Pubitemid 16054688)
23. Fabiato A, Fabiato F (1978b) Calcium induced release of calcium from the sarcoplasmic reticulum and skinned fibers from adult human, dog, cat, rabbit, rat, and frog hearts and fetal and newborn rat ventricles. Ann NY Acad Sci 307: 491-522
24. Feldman AM, Bristow MR, Parmley WW, Carson PE, Pepine CJ, Gilbert EM, Strobeck, JE, Hendrix GH, Power ER, Bain RP (1993) Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. New Eng J Med 329 (3): 149-155 (Pubitemid 23195734)
25. Feldman MC, Gwarthmey JC, Phillips P, Schoen F, Morgan JP (1988) Reversal of the force-frequency relationship in working myocardium from patients with end-stage heart failure. J Appl Cardiol 3: 273-283
26. Filkins JP (1985) Monokines and the metabolic pathophysiology of septic shock. Federation Proceedings 44: 300-304 (Pubitemid 15173206)
27. Finkel MS, Oddis CV, Jacobs TD, Watkins SC, Hattler BG, Simmons RL (1992) Inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257: 387-389
28. Finkel MS, Oddis CV, Mayer OH, Hattler BG, Simmons RL (1995) Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharm Exp Ther 272: (No 2): 945-952
29. Finkel MS, Shen L, Oddis CV, Hoffman RA, Romeo RC, Simmons RL, Hattler BG (1993) IL-6 as a mediator of stunned myocardium. Am J of Cardiol 71: 1231-1232
30. Finkel MS, Oddis CV, Romeo RC, Salama G (1993) Positive inotropic effect of acetylcysteine in the cardiomyopathic Syrian hamster. J Card Pharm 21: 29-34 (Pubitemid 23006623)
31. Freeswick PD, DiSilvio M, Nussler AK, Shah NS, Nguyen D, Billiar TR, Finkel MS, Hattler BG (1993) Evidence for inducible nitric oxide synthase expression in the heart. Surgical Forum 44: 267-269
32. Frering B, Philip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM (1994) Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Sur 108: 636-641 (Pubitemid 24330238)
33. Giroir BP, Horton JW, White DJ, McIntyre KL, Lin CQ (1994) Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 267 (Heart Circ Physiol 36): H118-H124
34. Guillen I, Blanes M, Gomez-Lechon MJ, Castell JV (1995) Cytokine signaling during myocardial infarction: Sequential appearance of IL-1 and IL-6. Am J Physiol 269 (Regulatory Integrative Comp Physiol 38): R229-R235
35. Gulick T, Chung MK, Peiper SJ, Lange LG, Schreiner GF (1989) Interleukin-1 and tumor necrosis factor inhibit cardiac myocytes b-adrenergic responsiveness. Proc Natl Acad Sci USA 86: 6753-6757 (Pubitemid 19236340)
36. Hack CE, DeGroot ER, Felt-Bersma RJF, Nujens JH, Strack Van Schijndel RJM, Erenberg-Belmer AJM, Thys LG, Aarden LA(1989) Increased plasma levels of interleukin- 6 in sepsis. Blood 74: 1704-1710 (Pubitemid 19251549)
37. Harding P, Carretero OA, LaPointe MC (1995) Effects of interleukin-1 beta and nitric oxide on cardiac myocytes. Hypertension 25 (3): 421-430
38. Hartzell HC (1988) Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems. Prog Biophys Molec Biol 52: 165-247
39. Hasselbach Wand Oetliker H (1983) Energetics and electrogenicity of the sarcoplasmic reticulum calcium pump. Annu Rev Physiol 45: 325-339
40. Hattler BG, Gorcsan JIII, Shah N, Oddis CV, Billiar TR, Simmons RL, Finkel MS (1994) Apotential role for nitric oxide (NO) in myocardial stunning. J Card Surg 9: 425-429 (Pubitemid 24171179)
41. Hattler BG, Oddis CV, Zeevi A, Luss H, Shah N, Geller DA, Billiar TR, Simmons RL, Finkel MS (1995) Regulation of constitutive nitric oxide synthase activity by the human heart. Am J Cardiol 76: 957-959
42. Hattler BG, Zeevi A, Oddis CV, Finkel MS (1995) Cytokine Induction during cardiac surgery: analysis of TNF-a expression preand post-cardiopulmonary bypass. J Card Surg 10: 418-422
43. Heyndrickx GR, Millard RW, McRitchie RJ, et al. (1975) Regional myocardial functional and electrophysiological alterations after brief coronary occlusion in conscious dog. J Clin Invest 56: 978-985
44. Hoffman BB, Lefkowitz RJ (1996) Goodman and Gilman's the Pharmacologic Basis of Therapeutics 8th Edition: Gilman AG, Rall TW, Nies AS, Taylor P. Pergamon Press, Inc., pp 187-243
45. Hosey MM, Lazdunski M (1988) Calcium channels: Molecular pharmacology, structure and regulation. J Membr Biol 104: 81-105
46. Hung JW, Lew YW (1993) Cellular mechanisms of endotoxin-induced myocardial depression in rabbits. Circulation Research 73: 125-134
47. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endotheliumderived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269
48. Ikeda U, Ohkawa F, Seino Y, Yamamotor K, Hidaka Y, Kasahara T, Kawai T, Shimada K (1992) Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 24: 579-584
49. Ikemoto N (1982) Structure and function of the calcium pump protein of sarcoplasmic reticulum. Ann Rev Physiol 44: 297-315
50. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD (1992) Cloning and expression of cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267: 14519-14522
51. Jones LG, Goldstein D and Brown JH (1988) Guanine nucleotide-dependent inositol triphosphate formation in chick heart cells. Circ Res 62: 299-305 (Pubitemid 18041951)
52. Kanai AJ, Mesaros S, Finkel MS, Oddis CV, Strauss HC, Malinski T (1997) Nitric oxide release measured directly with a porphyrinic microsensor reveals adrenergic control of constitutive nitric oxide synthase in cardiac myocytes. Am J Physiol 273 (42): C1371-C1377
53. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijoi R, LeJemtel TH (1994) Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation 90: 12-16
54. Katz AM (1992) Physiology of the Heart, 2nd ed. New York: Raven Press
55. Kawamura T, Wakusawa R, Okada K, Inada S (1993) Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 40: 11; 1016-1021 (Pubitemid 23356329)
56. Levine B, Kalman J, Mayer L, Filit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Eng J of Med 323 (4): 236-241 (Pubitemid 20225044)
57. Liu MS, Xuan YT (1986) Mechanisms of endotoxin-induced impairment in Na+-Ca++ exchange in canine myocardium. Am J Physiol 251 (Regulatory Integrative Comp Physiol 20): R1078-R1085
58. 2+ release from canine cardiac sarcoplasmic reticulum following endotoxin administration. Biochem and Biophys Res Comm 174 (No. 3): 1248-1254
59. 2+ current by interleukin-1 beta in cultured rat ventricular myocytes. Am J Physiol 268 (2Pt1): C339-349
60. Lowenstein CJ, Snyder SH (1992) Nitric oxide, a novel biologic messenger. Cell 70: 705-707
61. Lyons C, Orloff B, Cunningham J (1992) Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem 267: 6370-6374
62. Mann DL, Young JB (1994) Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 105: 897-904 (Pubitemid 24088479)
63. Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S (1994) Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circ 89: 955-958 (Pubitemid 24076518)
64. Neumann DA, Lane R, Allen GS, Herskowitz A, Rose, NR (1993) Viral myocarditis leading to cardiomyopathy: Do cytokines contribute to pathogenesis? Clin Immunology and Immunopathology 68 (No 2): 181-190 (Pubitemid 23278071)
65. Oddis CV, Simmons RL, Hattler BG, Finkel MS (1994) Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, L-NMMA, on cardiac myocytes. Biochem and Biophys Res Comm 205 (No 2): 992-997
66. Oddis CV and Finkel MS (1995) Norepinephrine enhances expression of inducible nitric oxide synthase by cardiac myocytes. Circulation 92 (8): I567
67. Oddis CV and Finkel MS (1995) Cytokinestimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes. Biochem and Biophys Res Comm 213: (No 3): 1002-1009
68. Oddis CV, Simmons RL, Hattler BG, Finkel MS (1995) cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol H38 (6): 2044-2050
69. Ognibene FP, Rosenberg SA, Lotze MT, Skibber J, Parker MM, Shelhamer JH, Parillo JE (1988) Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 94: 750-754
70. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM (1995) Effect of carvedilol on the survival of patients with chronic heart failure. Supplement 1 Circ 92 (8): I-142
71. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS (1992) Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-a in conscious dogs. J Clin Invest 90: 389-398
72. Palmer RMJ, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666
73. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526 (Pubitemid 17085822)
74. Parillo JE (1993) Mechanisms of disease: Pathogenic mechanisms of septic shock. N Eng J Med 328: 1471-1477
75. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE (1985) Profound but reversible myocardial depression in patients with septic shock. Annals of Internal Medicine 100: 483-490
76. Poggioli J, Sulpice JC and Vassort G (1986) Inositol phosphate production following a1-adrenergic, muscarinic, or electrical stimulation in isolated rat heart. FEBS Lett 206: 292-298 (Pubitemid 16008437)
77. Prabhu SD and Salama G (1990) The heavy metal ions Ag+ and Hg+ trigger calcium release from cardiac sarcoplasmic reticulum. Arch Biochem Biophys 277: 47-55 (Pubitemid 20078883)
78. Reilly JM, Cunnion RE, Burch-Whitman C, Parker MM, Shelhamer JH, Parrillo JE (1989) Acirculating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock. Chest 95: 1072-1080 (Pubitemid 19137004)
79. Reuter H and Scholtz H (1977) The regulation of the Ca++ conductance of cardiac muscle by adrenaline. J Physiol 264: 49-62 (Pubitemid 8029820)
80. Roberts AB, Roche NS, Winokur TS, Burmester JK, Sporn MB (1992) Role of transforming growth factor-B in maintenance of function of cultured neonatal cardiac myocytes. J Clin Invest 90: 2056-2062
81. Rozanski GJ, Witt RC (1994) IL-1 inhibits beta-adrenergic control of cardiac calcium current: Role of L-arginine/nitric oxide pathway. Am J Phys 267 (5Pt2): H1753-1758
82. Saven JJ, Peirce G, Katcher AH, Sheldon WF (1961) Correlation of intramyocardial electrocardiograms with polarographic oxygen and contractility in the nonischemic and regional ischemic left ventricle. Circ Res 9: 1268-1275
83. Scholtz JB, Schaeffer W, Schmitz H, Scholtz M, Steinfath M, Lohse U, Schwabe, Puurunen J (1988) Alpha-1 adrenoreceptor-mediated positive inotropic effect and inositol triphosphate increase in mammalian heart. J Pharmacol Exp Ther 245: 335-337
84. Smith LW, McDonough KH (1988) Inotropic sensitivity to b-adrenergic stimulation in early sepsis. Am J Physiol 255 (Heart Circ Physiol 24): H699-H703
85. Sobotka PA, McMannis J, Fisher RI, Stein DG, Thomas JX Jr (1990) Effects of interleukin- 2 on cardiac function in the isolated rat heart. J Clin Invest 86: 845-850 (Pubitemid 20327374)
86. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM (1993) Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106: 1008-1016 (Pubitemid 24018542)
87. Sultzer BM (1968) Genetic control of leukocyte responses to endotoxin. Nature 219: 1253-1254
88. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM (1992 High brochoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon and elastase, in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am Rev Respir Dis 145: 1016-1022
89. Tanford C (1983) Mechanism of free energy coupling in active transport. Ann Rev Biochem 52: 379-409
90. Thaik CM, Calderone A, Takahashi N, Colucci WS (1995) Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Inv 96 (2): 1093-1099
91. Thomas JA, Marks BH (1978) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41: 233
92. 2+ currents in rat ventricular myocytes. J Physiol 477.2: MS2249: 237-252 (Pubitemid 2091104)
93. Vaitkus PT, Grossman D, Fox KR, McEvoy MD, Doherty JV (1990) Complete heart block due to interleukin-2 therapy. Am Heart J, pp 978-980 (Pubitemid 20133911)
94. Vincent JL, Bakker J, Marecaux G, Schandene L, Kahn RJ, Dupont E (1992) Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Chest 101: 810-815
95. Weinberg JR, Wright DJM, Guz A (1988) Interleukin-1 and tumor necrosis factor cause hypotension in the conscious rabbit. Clinical Science 75: 251-255
96. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228
97. Yoshida T, Okumura H, Kaya H, Okabe Y, Matano S, Ohtake S, Nakamura S, Matsuda T (1993) Prevention of doxuribicininduced cardiotoxicity by recombinant interleukin-1 in hamsters. Doxorubicin cardiotoxicity and interleukin-1. Biotherapy 6 (2): 125-132 (Pubitemid 23278536)
98. Zeilender S, Davis D, Fairman RP, Glauser FL (1989) Inotropic and vasoactive drug treatment of interleukin-2 induced hypotension in sheep. Cancer Research 49: 4423-4426 (Pubitemid 19208337)